Yubo International Biotech Ltd. engages in the supply of products that process, store, and administer therapeutic doses of endometrial stem cells for the treatment of disease and injuries. The company is headquartered in Beijing, Beijing and currently employs 18 full-time employees. The firm focuses on the research and development and application of endometrial stem cells and offers its products and services under the brand VIVCELL. The Company’s product offerings include healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. The firm also offers stem cell related services including cell testing and health management consulting services.
根据最新的财务报表(Form-10K),Yubo International Biotech Ltd 的总资产为 $1,净损失为 $-1
YBGJ 的关键财务比率是什么?
Yubo International Biotech Ltd 的流动比率是 0.33,净利 margin 为 0,每股销售为 $0。
Yubo International Biotech Ltd 的收入按细分市场或地理位置如何划分?
Yubo International Biotech Ltd 最大收入来源是 Health Management and Health Maintenance Services,在最近的收益报告中收入为 604,676。就地区而言, China 是 Yubo International Biotech Ltd 的主要市场,收入为 604,676。
Yubo International Biotech Ltd 是否盈利?
不,根据最新的财务报表,Yubo International Biotech Ltd 的净损失为 $-1